arrow
Back
P

Prebet, Thomas

bristol myers squibb

0H-index
1Paper Count
0Citation Count
Published Papers 69
Publication Date
CPX-351 Selectively Benefits Patients with AML and Myelodysplasia-Related Mutations in the Pivotal Randomized Trial
err2026-02-04
err0
errOAAI
errShai Shimony; H. Moses Murdock; Julia Keating; Harrison K. Tsai; Archana Sasi; Christopher J. Gibson; Stefan Faderl; Anthony Wagner; Nalina Dronamraju; Tara L. Lin; Thomas Prebet; Jorge E. Cortes; Geoffrey L. Uy; Jeffrey E. Lancet; Christopher R. Reilly; Donna Neuberg; Richard M. Stone; R. Coleman Lindsley
errShare
errSave
Oral azacitidine maintenance therapy for patients with acute myeloid leukaemia and myelodysplasia-related changes: Post hoc analysis of the QUAZAR AML-001 trial
err2025-12-12
err0
PREAI
errMaria Teresa Voso; Stéphane de Botton; Michael Pfeilstöcker; Angela Figuera Alvarez; Kefeng Wang; Wendy L. See; Manuel Ugidos Guerrero; Daniel Lopes de Menezes; Erica Petrlik; Thomas Prebet; Gail J. Roboz
errShare
errSave
Evaluation of the pharmacokinetics of enasidenib in patients with hepatic impairment
err2025-07-11
err0
PREAI
errYiming Cheng; Jian Chen; Carlos Vigil; Shahram Khanzadeh; Anita Rampersad; Thomas Prebet; Yan Li
errShare
errSave
Real-world treatment patterns and outcomes with oral azacitidine maintenance therapy in patients with acute myeloid leukemia
errCANCER
IF5.1
err2025-04-15
err0
PREAI
errLeber, Brian; Ruiz, Marcia T.; Elgendy, Hany; Pettersson, Filippa; Prebet, Thomas; Vigil, Carlos E.; Parikh, Rohan C.; Korgaonkar, Siddhi; Bello, Fareedat; Davis, Keith L.; Gaugler, Lona; Strocchia, Maria; Sieluk, Jan; Li, Yeran; Schuh, Andre C.
errShare
errSave
Healthcare Utilization and Costs Among Patients with Acute Myeloid Leukemia Receiving Oral Azacitidine Maintenance Therapy Versus No Maintenance: A US Claims Database Study
err2024-09-06
err0
errOAAI
errBorate, Uma; Seiter, Karen; Potluri, Ravi; Mazumder, Debasish; Chevli, Manoj; Prebet, Thomas; Gaugler, Lona; Strocchia, Maria; Vasconcelos, Alberto; Sieluk, Jan
errShare
errSave
Luspatercept versus epoetin alfa in erythropoiesisstimulating agent-naive, transfusion-dependent, lower-risk myelodysplastic syndromes (COMMANDS): primary analysis of a phase 3, open-label, randomised, controlled trial
err2024-09-01
err1
PREAI
errPorta, Matteo Giovanni Della; Garcia-Manero, Guillermo; Santini, Valeria; Zeidan, Amer M.; Komrokji, Rami S.; Shortt, Jake; Valcarcel, David; Jonasova, Anna; Dimicoli-Salazar, Sophie; Tiong, Ing Soo; Lin, Chien-Chin; Li, Jiahui; Zhang, Jennie; Pilot, Richard; Kreitz, Sandra; Pozharskaya, Veronika; Keeperman, Karen L.; Rose, Shelonitda; Prebet, Thomas; Lai, Yinzhi; Degulys, Andrius; Paolini, Stefania; Cluzeau, Thomas; Fenaux, Pierre; Platzbecker, Uwe
errShare
errSave
Efficacy and safety of luspatercept versus epoetin alfa in erythropoiesis-stimulating agent-naive, transfusion- dependent, lower-risk myelodysplastic syndromes (COMMANDS): interim analysis of a phase 3, open-label, randomised controlled trial
errLANCET
IF88.5
err2023-07-01
err60
PREAI
errPlatzbecker, Uwe; Della Porta, Matteo Giovanni; Santini, Valeria; Zeidan, Amer M.; Komrokji, Rami S.; Shortt, Jake; Valcarcel, David; Jonasova, Anna; Dimicoli-Salazar, Sophie; Tiong, Ing Soo; Lin, Chien-Chin; Li, Jiahui; Zhang, Jennie; Giuseppi, Ana Carolina; Kreitz, Sandra; Pozharskaya, Veronika; Keeperman, Karen L.; Rose, Shelonitda; Shetty, Jeevan K.; Hayati, Sheida; Vodala, Sadanand; Prebet, Thomas; Degulys, Andrius; Paolini, Stefania; Cluzeau, Thomas; Fenaux, Pierre; Garcia-Manero, Guillermo
errShare
errSave
Venetoclax plus azacitidine compared with intensive chemotherapy as induction for patients with acute myeloid leukemia: retrospective analysis of an electronic medical record database in the United States (vol 102, pg 749, 2023)
err2023-06-21
err0
errOAAI
errZeidan, Amer M.; Pollyea, Daniel A.; Borate, Uma; Vasconcelos, Alberto; Potluri, Ravi; Rotter, David; Kiendrebeogo, Zephirin; Gaugler, Lona; Prebet, Thomas; Strocchia, Maria; Bonifacio, Gaetano; Chen, Clara
errShare
errSave
Survival outcomes with oral azacitidine maintenance in patients with acute myeloid leukemia in remission by receipt of initial chemotherapy: subgroup analyses from the phase III QUAZAR AML-001 trial
err2023-03-23
err1
errOAAI
errWei, Andrew H.; Roboz, Gail J.; Dombret, Herve; Doehner, Hartmut; Schuh, Andre C.; Montesinos, Pau; Selleslag, Dominik; Bondarenko, Sergey N.; Prebet, Thomas; Lai, Yinzhi; Skikne, Barry; Beach, C. L.; Ravandi, Farhad
errShare
errSave
Long-term survival with oral azacitidine for patients with acute myeloid leukemia in first remission after chemotherapy: Updated results from the randomized, placebo-controlled, phase 3 QUAZAR AML-001 trial
err2023-02-06
err4
errOAAI
errWei, Andrew H.; Doehner, Hartmut; Sayar, Hamid; Ravandi, Farhad; Montesinos, Pau; Dombret, Herve; Selleslag, Dominik; Porkka, Kimmo; Jang, Jun-Ho; Skikne, Barry; Beach, C. L.; Prebet, Thomas; Zhang, George; Risueno, Alberto; Ugidos, Manuel; See, Wendy L.; Menezes, Daniel; Roboz, Gail J.
errShare
errSave
Venetoclax plus azacitidine compared with intensive chemotherapy as induction for patients with acute myeloid leukemia: retrospective analysis of an electronic medical record database in the United States
err2023-02-03
err11
errOAAI
errZeidan, Amer M.; Pollyea, Daniel A.; Borate, Uma; Vasconcelos, Alberto; Potluri, Ravi; Rotter, David; Kiendrebeogo, Zephirin; Gaugler, Lona; Prebet, Thomas; Strocchia, Maria; Bonifacio, Gaetano; Chen, Clara
errShare
errSave
Olutasidenib alone or with azacitidine in IDH1-mutated acute myeloid leukaemia and myelodysplastic syndrome: phase 1 results of a phase 1/2 trial
err2023-01-01
err67
PREAI
errWatts, Justin M.; Baer, Maria R.; Yang, Jay; Prebet, Thomas; Lee, Sangmin; Schiller, Gary J.; Dinner, Shira N.; Pigneux, Arnaud; Montesinos, Pau; Wang, Eunice S.; Seiter, Karen P.; Wei, Andrew H.; De Botton, Stephane; Arnan, Montserrat; Donnellan, Will; Schwarer, Anthony P.; Recher, Christian; Jonas, Brian A.; Ferrell Jr, P. Brent; Marzac, Christophe; Kelly, Patrick; Sweeney, Jennifer; Forsyth, Sanjeev; Guichard, Sylvie M.; Brevard, Julie; Henrick, Patrick; Mohamed, Hesham; Cortes, Jorge E.
errShare
errSave
In vivo anti-tumor effect of PARP inhibition in IDH1/2 mutant MDS/AML resistant to targeted inhibitors of mutant IDH1/2
errLEUKEMIA
IF13.4
err2022-03-10
err19
errOAAI
errGbyli, Rana; Song, Yuanbin; Liu, Wei; Gao, Yimeng; Biancon, Giulia; Chandhok, Namrata S.; Wang, Xiaman; Fu, Xiaoying; Patel, Amisha; Sundaram, Ranjini; Tebaldi, Toma; Mamillapalli, Padmavathi; Zeidan, Amer M.; Flavell, Richard A.; Prebet, Thomas; Bindra, Ranjit S.; Halene, Stephanie
errShare
errSave
Azacitidine maintenance in AML post induction and posttransplant
err2022-01-10
err5
PREAI
errBewersdorf, Jan Philipp; Prebet, Thomas; Gowda, Lohith
errShare
errSave
Comprehensive Clinicopathologic and Molecular Analysis of Mast Cell Leukemia With Associated Hematologic Neoplasm: A Report and In-Depth Study of 5 Cases
err2021-09-13
err3
errOAAI
errLi, Philippa; Biancon, Giulia; Patel, Timil; Pan, Zenggang; Kothari, Shalin; Halene, Stephanie; Prebet, Thomas; Xu, Mina L. L.
errShare
errSave
Current challenges and unmet medical needs in myelodysplastic syndromes
errLEUKEMIA
IF13.4
err2021-05-28
err61
errOAAI
errPlatzbecker, Uwe; Kubasch, Anne Sophie; Homer-Bouthiette, Collin; Prebet, Thomas
errShare
errSave
A phase 1 study of the pan-bromodomain and extraterminal inhibitor mivebresib (ABBV-075) alone or in combination with venetoclax in patients with relapsed/refractory acute myeloid leukemia
errCANCER
IF5.1
err2021-05-02
err51
errOAAI
errBorthakur, Gautam; Odenike, Olatoyosi; Aldoss, Ibrahim; Rizzieri, David A.; Prebet, Thomas; Chen, Chris; Popovic, Relja; Modi, Dimple A.; Joshi, Rujuta H.; Wolff, Johannes E.; Jonas, Brian A.
errShare
errSave
Cost-effectiveness of azacitidine and venetoclax in unfit patients with previously untreated acute myeloid leukemia
err2021-02-16
err24
errOAAI
errPatel, Kishan K.; Zeidan, Amer M.; Shallis, Rory M.; Prebet, Thomas; Podoltsev, Nikolai; Huntington, Scott F.
errShare
errSave
Acute Myeloid Leukemia, Version 2.2021 Featured Updates to the NCCN Guidelines
err2021-01-06
err211
errOAAI
errPollyea, Daniel A.; Bixby, Dale; Perl, Alexander; Bhatt, Vijaya Raj; Altman, Jessica K.; Appelbaum, Frederick R.; de Lima, Marcos; Fathi, Amir T.; Foran, James M.; Gojo, Ivana; Hall, Aric C.; Jacoby, Meagan; Lancet, Jeffrey; Mannis, Gabriel; Marcucci, Guido; Martin, Michael G.; Mims, Alice; Neff, Jadee; Nejati, Reza; Olin, Rebecca; Percival, Mary-Elizabeth; Prebet, Thomas; Przespolewski, Amanda; Rao, Dinesh; Ravandi-Kashani, Farhad; Shami, Paul J.; Stone, Richard M.; Strickland, Stephen A.; Sweet, Kendra; Vachhani, Pankit; Wieduwilt, Matthew; Gregory, Kristina M.; Ogba, Ndiya; Tallman, Martin S.
errShare
errSave